Avoid common mistakes on your manuscript.
Correction to: Drug Safety (2023) 46:1161–1172 https://doi.org/10.1007/s40264-023-01348-7
We found a coding error in the way serious adverse drug events were being identified in our original analysis. After correcting this, there was an increase in the number of serious events in the included data for this manuscript (56.7% versus 28.5% as previously published). The number of reported deaths and hospitalizations doubled (i.e., 9 deaths versus < 5 as previously published; 1393 admissions versus 682 as previously published) and life-threatening events increased 6-fold (211 events now versus 35 as previously published).
After reclassification, sex no longer significantly impacted the adverse drug event outcomes patients experienced. Instead, we found that older patients were more likely to experience a serious outcome than younger patients (per 10 years; AOR = 1.13, 95% CI 1.09–1.18). These changes are applied to Figure 3, Tables 1 to 4. The corrected Fig. 3 and the Tables 1, 2, 3, 4 are given below.
Adjusted effects of patient age and sex on the outcome of adverse drug events (ADEs) reported (N = 3174). *We adjusted each estimate for the other variable in the regression (i.e., age for sex and sex for age) and for clustering by patient and presenting hospital
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
Funding for this work was provided by the Canadian Institutes of Health Research, with support from the Ministry of Health British Columbia, Vancouver Coastal Health, the Lower Mainland Consolidated Pharmacies, and the BC SUPPORT Unit. CMH is a Michael Smith Foundation for Health Research Health Professional-Investigator award holder. EL is supported by the Michael Smith Health Research BC Research Trainee Award. The funders have no role in the design, conduct, analysis, interpretation of data, or the drafting of scientific manuscripts.
Conflicts of interest
ActionADE’s intellectual property is jointly shared between the University of British Columbia and Simon Fraser University. None of the authors have any competing interests to declare.
Data transparency
Access to data can be requested through the Population Data BC Data Steward(s) or their designated service providers. All inferences, opinions, and conclusions drawn in this publication are those of the author(s), and do not reflect the opinions or policies of the Data Steward(s).
Additional information
Accordingly, the following headings under Declarations should be updated.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Cragg, A., Small, S.S., Lau, E. et al. Correction to: Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes. Drug Saf (2024). https://doi.org/10.1007/s40264-024-01452-2
Published:
DOI: https://doi.org/10.1007/s40264-024-01452-2